Evidence map›Paper›PMID 38776311›Full record

ArticlePloS one2024

Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS) and the COVID-19 mapping and mitigation in schools (CoMMinS) study.

Katharine J Looker, Elliot McClenaghan, Alison Judd, Livia Pierotti, Harriet Downing, Jody Phelan, Charlotte Warren-Gash, Kalu Ngozi, Fiona Dawe, Caroline Relton and 5 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Katharine J LookerPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-3375-0807
Elliot McClenaghanDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Alison JuddOffice for National Statistics, Newport, South Wales, United Kingdom.
Livia PierottiPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.
Harriet DowningPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.
Jody PhelanDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, LSHTM, London, United Kingdom.
Charlotte Warren-GashDepartment of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, LSHTM, United Kingdom.
Kalu NgoziDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Fiona DaweOffice for National Statistics, Newport, South Wales, United Kingdom.
Caroline ReltonPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.
Hannah ChristensenPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.
Alastair D HayPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.
Punam MangtaniDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Patrick Nguipdop-DjomoDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Rachel DenholmPopulation Health Sciences, University of Bristol, Bristol, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThe symptom profiles of acute SARS-CoV-2 infection and long-COVID in children and young people (CYP), risk factors, and associated healthcare needs, are poorly defined. The Schools Infection Survey 1 (SIS-1) was a nationwide study of SARS-CoV-2 infection in primary and secondary schools in England during the 2020/21 school year. The Covid-19 Mapping and Mitigation in Schools (CoMMinS) study was conducted in schools in the Bristol area over a similar period. Both studies conducted testing to identify current and previous SARS-CoV-2 infection, and recorded symptoms and school attendance. These research data have been linked to routine electronic health record (EHR) data.

aimsTo better understand the short- and long-term consequences of SARS-CoV-2 infection, and their risk factors, in CYP.

methodsRetrospective cohort and nested case-control analyses will be conducted for SIS-1 and CoMMinS data linked to EHR data for the association between (1) acute symptomatic SARS-CoV-2 infection and risk factors; (2) SARS-CoV-2 infection and long-term effects on health: (a) persistent symptoms; (b) any new diagnosis; (c) a new prescription in primary care; (d) health service attendance; (e) a high rate of school absence.

resultsOur study will improve understanding of long-COVID in CYP by characterising the trajectory of long-COVID in CYP in terms of things like symptoms and diagnoses of conditions. The research will inform which groups of CYP are more likely to get acute- and long-term outcomes of SARS-CoV-2 infection, and patterns of related healthcare-seeking behaviour, relevant for healthcare service planning. Digested information will be produced for affected families, doctors, schools, and the public, as appropriate.

conclusionLinked SIS-1 and CoMMinS data represent a unique and rich resource for understanding the impact of SARS-CoV-2 infection on children's health, benefiting from enhanced SARS-CoV-2 testing and ability to assess a wide range of outcomes.

Indexed as

COVID-19SARS-CoV-2SchoolsAdolescentCase-Control StudiesChildEnglandFemaleHumansMaleRetrospective StudiesRisk Factors

Identifiers

PMID38776311
PMCPMC11111005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.